Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators
- 1 October 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 180, 253-267
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2012-006431)
- National Research Foundation of Korea
This publication has 102 references indexed in Scilit:
- The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in InflammationGenes, 2013
- Nodakenin Suppresses Lipopolysaccharide-Induced Inflammatory Responses in Macrophage Cells by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 and Nuclear Factor-κB Pathways and Protects Mice from Lethal Endotoxin ShockThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approachNucleic Acids Research, 2012
- Macrophage-mediated inflammation in metabolic diseaseNature Reviews Immunology, 2011
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- Trophic macrophages in development and diseaseNature Reviews Immunology, 2009
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Inflammation and cancerNature, 2002